Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 1
1990 1
1991 1
1992 2
1993 3
1994 2
1995 3
1996 2
1997 1
1998 2
1999 2
2000 10
2001 4
2002 6
2003 4
2004 4
2005 4
2006 1
2007 5
2008 8
2009 5
2010 4
2012 2
2013 4
2014 4
2015 2
2016 7
2017 8
2018 11
2019 16
2020 11
2021 12
2022 12
2023 21
2024 16
2025 21
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: MEDLINE. Clear all
Page 1
Frailty and postoperative outcomes following craniopharyngioma resection: a multicenter Registry for Adenomas of the Pituitary and Related Disorders analysis.
Kelleher ST, Chen AY, Feng R, Collopy C, Rennert RC, Couldwell WT, Kshettry VR, Gardner P, Silverstein JM, Kim AH, Barkhoudarian G, Kelly D, Pacione DR, Suryadevara CM, Kim W, Bergsneider M, Chicoine MR, Zada G, Wu KC, Prevedello DM, Benjamin C, Catalino MP, Mamelak A, Cheok SK, Zwagerman NT, Van Gompel JJ, Palit SR, Fernandez-Miranda JC, Yuen KCJ, Little AS, Karsy M, Evans JJ. Kelleher ST, et al. Neurosurg Focus. 2026 Jun 1;60(6):E7. doi: 10.3171/2026.2.FOCUS251160. Neurosurg Focus. 2026. PMID: 42224740
OBJECTIVE: Frailty is a known predictor of adverse outcomes in pituitary surgery, yet its impact regarding craniopharyngioma remains unclear. The authors assessed preoperative frailty, measured by the 11-factor modified frailty index (mFI-11), and its association wi …
OBJECTIVE: Frailty is a known predictor of adverse outcomes in pituitary surgery, yet its impact regarding craniopharyngioma r …
The role of postoperative radiation therapy in short- and long-term survival for craniopharyngiomas: a National Cancer Database analysis.
Alexander AY, Agosti E, Michalopoulos G, Kerezoudis P, Fontanella MM, Daniels DJ, Peris Celda M. Alexander AY, et al. Neurosurg Focus. 2026 Jun 1;60(6):E8. doi: 10.3171/2026.2.FOCUS251161. Neurosurg Focus. 2026. PMID: 42224730
METHODS: The authors queried the National Cancer Database for patients diagnosed with craniopharyngioma between 2004 and 2017. Tumor characteristics, treatment strategies, and extent of resection were analyzed. Endpoints were 3-month mortality rate and OS, which were compa …
METHODS: The authors queried the National Cancer Database for patients diagnosed with craniopharyngioma between 2004 and 2017. Tumor …
Predictors of hospital length of stay, discharge disposition, and readmission after craniopharyngioma surgery: a multicenter study from the RAPID database.
Tenhoeve SA, Tang A, Orton CJ, Gautam D, Abdul-Rahman NH, Silverstein JM, Kim AH, Evans JJ, Barkhoudarian G, Fernandez-Miranda JC, Pacione DR, Kim W, Bergsneider M, Chicoine MR, Zada G, Kshettry VR, Wu KC, Benjamin CG, Van Gompel J, Palit SR, Catalino MP, Mamelak AN, Zwagerman NT, Cheok SK, Little AS, Zenonos GA, Karsy M, Morshed RA, Blackburn SL, Mukherjee D, Beer-Furlan A, Couldwell WT, Gardner PA, Rennert RC. Tenhoeve SA, et al. Neurosurg Focus. 2026 Jun 1;60(6):E6. doi: 10.3171/2026.2.FOCUS251047. Neurosurg Focus. 2026. PMID: 42224727
OBJECTIVE: Craniopharyngiomas are benign intracranial tumors that can be difficult to manage operatively and often result in postoperative complications and prolonged recovery. ...CONCLUSIONS: Cognitive and functional status, systemic comorbidities, and postoperative compl …
OBJECTIVE: Craniopharyngiomas are benign intracranial tumors that can be difficult to manage operatively and often result in postoper …
Comparison of clinical outcomes in adamantinomatous and papillary craniopharyngioma: a baseline analysis before the targeted therapy era.
Damante MA, Juncker RB, Kim AH, Evans JJ, Barkhoudarian G, Fernandez-Miranda JC, Pacione DR, Kim W, Chicoine MR, Zada G, Kshettry VR, Benjamin C, Van Gompel J, Catalino M, Mamelak A, Zwagerman N, Little AS, Pacult MA, Gardner P, Karsy M, Couldwell WT, Rennert RC, Palmer JD, Prevedello DM, Wu KC. Damante MA, et al. Neurosurg Focus. 2026 Jun 1;60(6):E11. doi: 10.3171/2026.2.FOCUS251172. Neurosurg Focus. 2026. PMID: 42224722
METHODS: The authors queried the Registry for Adenomas of the Pituitary and Related Disorders (RAPID) database, which encompassed patients from 14 participating institutions across the United States between 2000 and 2024. ...Patient demographic characteristics, clinical co …
METHODS: The authors queried the Registry for Adenomas of the Pituitary and Related Disorders (RAPID) database, which encompassed pat …
Risk factors for postoperative cerebrospinal fluid leak following endoscopic transsphenoidal surgery for craniopharyngioma: a multicenter cohort study with a contemporary surgeon practice survey.
Palit SR, Shinya Y, Celda MP, Karsy M, Evans JJ, Chicoine MR, Kim AH, Patel B, Kim W, Bergsneider M, Pacione DR, Gardner P, Mukherjee D, Liu C, Cheok S, Zwagerman NT, Christenson C, Blackburn S, Kshettry VR, Rennert RC, Couldwell WT, Morshed R, Wu KC, Prevedello D, Barkhoudarian G, Fernandez-Miranda JC, Zada G, Benjamin C, Catalino MP, Mamelak A, Beer Furlan A, Zenonos G, Mendoza MM, Little AS, Van Gompel JJ. Palit SR, et al. J Neurooncol. 2026 May 21;178(1):13. doi: 10.1007/s11060-026-05627-y. J Neurooncol. 2026. PMID: 42165967
METHODS: A retrospective review was conducted on 416 patients who underwent endoscopic transsphenoidal surgery (ETS) for craniopharyngioma from 20 institutions. Factors were compared between patients with and without postoperative CSF leak, and between Early (2007-2 …
METHODS: A retrospective review was conducted on 416 patients who underwent endoscopic transsphenoidal surgery (ETS) for crani …
Multi-center comparison of corticotropin releasing hormone vs. desmopressin stimulation responses in inferior petrosal sinus sampling for Cushing's disease.
Tenhoeve SA, Silverstein JM, Kim AH, Evans JJ, Collopy C, Rennert R, Couldwell WT, Barkhoudarian G, Dan Kelly, Fernandez-Miranda JC, Pacione DR, Kim W, Bergsneider M, Chicoine MR, Zada G, Kshettry VR, Wu K, Benjamin C, Van Gompel J, Catalino MP, Mamelak A, Zwagerman N, Furlan A, Little AS, Yuen KC, Gardner P, Fazeli P, Karsy M; RAPID Consortium. Tenhoeve SA, et al. Clin Neurol Neurosurg. 2026 Jul;266:109393. doi: 10.1016/j.clineuro.2026.109393. Epub 2026 Mar 14. Clin Neurol Neurosurg. 2026. PMID: 41855849 Free article.
METHODS: Data from the multi-center Registry of Adenomas of the PItuitary and Related Disorders (RAPID) was evaluated. 93 patients with CD confirmed by pathology or biochemical remission that underwent IPSS testing prior to surgical resection (desmopressin [n = 57], …
METHODS: Data from the multi-center Registry of Adenomas of the PItuitary and Related Disorders (RAPID) was evaluated. 93 patients wi …
Association of standard postoperative day 1 discharge following endonasal surgery for pituitary adenoma with lower complication rates and unplanned medical care.
Rindler RS, Dang DD, Kumar R, Herndon J, Erickson D, Davidge-Pitts C, Bancos I, Choby G, Atkinson J, Van Gompel JJ. Rindler RS, et al. J Neurosurg. 2026 Jan 23;144(4):929-936. doi: 10.3171/2025.9.JNS25752. Print 2026 Apr 1. J Neurosurg. 2026. PMID: 41576384
OBJECTIVE: Early discharge following uncomplicated endonasal resection of pituitary adenoma has been described as safe and feasible. Discharge on postoperative day (POD) 1 is not a widely implemented practice in the United States. ...METHODS: A retrospective database revie …
OBJECTIVE: Early discharge following uncomplicated endonasal resection of pituitary adenoma has been described as safe and feasible. …
Rebirth of an old modality: revisiting intraoperative ultrasound in pituitary surgery.
Borghei-Razavi H, Van Gompel JJ. Borghei-Razavi H, et al. Pituitary. 2025 Dec 9;29(1):13. doi: 10.1007/s11102-025-01621-1. Pituitary. 2025. PMID: 41364378
Pituitary adenomas are prevalent intracranial tumors that, though benign, present surgical challenges due to their anatomy and hormonal behavior. Transsphenoidal surgery is the standard approach, but differentiation between normal gland and aden …
Pituitary adenomas are prevalent intracranial tumors that, though benign, present surgical challenges due to their anat …
Depth of invasion: Surgical management and outcomes for non-functioning pituitary neuroendocrine tumors in the cavernous sinus KNOSP 3 and 4.
Palavani LB, Ribeiro FV, Nogueira BV, Ferreira MY, Mitre LP, Andreão FF, Brenner LO, Bertani R, Negri H, Macedo L, Oberman DZ, Beer-Furlan A, Almeida JP, Landeiro JA. Palavani LB, et al. J Clin Neurosci. 2026 Jan;143:111751. doi: 10.1016/j.jocn.2025.111751. Epub 2025 Nov 20. J Clin Neurosci. 2026. PMID: 41270357
BACKGROUND: Nonfunctioning Pituitary Neuroendocrine Tumors (NFPitNETs) account for 14 %-54 % of all pituitary tumors and 10-15 % of primary intracranial tumors. ...These tumors may extend into critical areas, especially into the cavernous …
BACKGROUND: Nonfunctioning Pituitary Neuroendocrine Tumors (NFPitNETs) account for 14 %-54 % of all pituitary tumors …
Impact of the extent of tumor resection on adrenal function recovery after transsphenoidal surgery for nonfunctioning pituitary adenomas.
Shinya Y, Herndon JS, Palit SR, Hong S, Erickson D, Bancos I, Donegan D, Pinheiro Neto C, Meyer FB, Atkinson JLD, Van Gompel JJ. Shinya Y, et al. J Neurosurg. 2025 Nov 7;144(3):624-632. doi: 10.3171/2025.6.JNS25607. Print 2026 Mar 1. J Neurosurg. 2025. PMID: 41202274
OBJECTIVE: While endonasal transsphenoidal surgery (ETS) is the standard treatment for nonfunctioning pituitary adenomas (NFPAs), the postoperative recovery rates of secondary adrenal insufficiency and their predictive factors remain poorly understood. ...CON …
OBJECTIVE: While endonasal transsphenoidal surgery (ETS) is the standard treatment for nonfunctioning pituitary adenoma …
208 results